Home/Filings/4/0001415889-25-009633
4//SEC Filing

Zeronda Tyler 4

Accession 0001415889-25-009633

CIK 0001566044other

Filed

Apr 1, 8:00 PM ET

Accepted

Apr 2, 4:15 PM ET

Size

5.1 KB

Accession

0001415889-25-009633

Insider Transaction Report

Form 4
Period: 2025-03-31
Zeronda Tyler
CHIEF FINANCIAL OFFICER
Transactions
  • Tax Payment

    Common Stock

    2025-03-31$1.58/sh8,399$13,270118,493 total
Footnotes (1)
  • [F1]Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units.

Issuer

VYNE Therapeutics Inc.

CIK 0001566044

Entity typeother

Related Parties

1
  • filerCIK 0001867033

Filing Metadata

Form type
4
Filed
Apr 1, 8:00 PM ET
Accepted
Apr 2, 4:15 PM ET
Size
5.1 KB